Decrypting Cancer’s Code: The Next Generation

Precision oncology, enabled by the convergence of diverse expertise (oncologists, pathologists, bioinformaticians/systems biologists, and biostatisticians, among others), is the current standard of care as customized treatment plans can now be developed for each patient based on the specific molecular aberrations present in their tumor. As part of our lab’s focus on translational oncology, we integrate in silico analyses, in vitro and in vivo experiments, and clinical data analyses to identify and validate novel and robust biomarkers within well-delineated cancer subtypes to help translate their untapped power into routine clinical practice.